Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Philogen
Research
New immuno-oncology combo attacks glioblastoma in mice
A protein-based drug that fuses immune-stimulating cytokines with antibodies that target glioblastoma slowed tumor growth in mouse models.
Arlene Weintraub
Oct 7, 2020 2:00pm
EuroBiotech Report—Bayer, Merck, F-star, Philogen and roxa data
May 16, 2019 9:59am
Italian cancer startup Philogen gets off impressive $70M round
May 13, 2019 8:38am
